0001209191-23-052535.txt : 20231010 0001209191-23-052535.hdr.sgml : 20231010 20231010164455 ACCESSION NUMBER: 0001209191-23-052535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231005 FILED AS OF DATE: 20231010 DATE AS OF CHANGE: 20231010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lagarde Michel CENTRAL INDEX KEY: 0001518973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 231318475 MAIL ADDRESS: STREET 1: 450 LEXINGTON AVE., 31ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-10-05 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001518973 Lagarde Michel C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVE BOSTON MA 02210 1 0 0 0 0 Common Stock 2023-10-05 4 A 0 1132 0.00 A 1132 D Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. /s/ Christiana Stevenson, Attorney-in-Fact 2023-10-10